Experimental and Clinical Studies of Retinal Stimulation (NCT03635645)

🧪 Interventions in This Study

• New visual processing unit (VPU) with asymmetric waveforms (DEVICE)
• New VPU with bipolar stimulation (DEVICE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• University of Michigan — Ann Arbor, Michigan

📞 Contact the Study Coordinator

Phone: (661) 713-4603

Email: weiland@umich.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Retinitis Pigmentosa

• Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP) — Phoenix, Arizona
• Natural History of PRPF31 Mutation-Associated Retinal Dystrophy — San Francisco, California
• Prospective Natural History Study of Retinitis Pigmentosa — Pittsburgh, Pennsylvania
• Study to Evaluate Safety of RTx-015 Injection in Retinitis Pigmentosa or Choroideremia Patients (ENVISION) — Beverly Hills, California
• FIGHT-RP 1 Extension Study — Baltimore, Maryland
• Promising ROd-cone DYstrophy Gene therapY — Miami, Florida

Explore by condition: All Retinitis Pigmentosa clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.